IUX24
TopMarketWorldEconomyFinanceTechnologyBusinessPoliticsAnalysis & Opinion

Windward Bio Raises 175 Million in US IPO

Novo Holdings backed Windward Bio raised 175 million dollars in its US initial public offering after pricing shares at 17 dollars each. The company develops antibody medicines and will start trading on Friday.

Xurve View
Insights:
The logo of Novo at the company's booth at the 9th China International Import Expo (CIIE) in Shanghai, China, November 6, 2026. REUTERS/Go Nakamura

Windward Bio raised $175 million in its United States initial public offering on Thursday after pricing 10.3 million shares at $17 apiece. The offering sat comfortably within the marketed range of $16 to $18 per share. The Basel, Switzerland-based biotech will begin trading on Friday under the ticker WWB.